Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $5.2969 per EA under NDC 00054065025. Its NADAC has been published 185 times since Mar 22, 2023.
FDA first approved this application on Jan 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP
Butalbital, Acetaminophen, Caffeine and Codeine PhosphateStrength
300; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054065025
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA215138FDA Approved
1/26/2022
TE Code
AB
On Market Since
5/9/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has been published 185 times since Mar 22, 2023, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.2969 per EA |
|---|---|
| All-time high | $5.6960 (Apr 10, 2024) |
| All-time low | $4.1553 (Feb 19, 2025) |
| 52-week high | $5.3507 |
| 52-week low | $4.9748 |
| Median price | $5.2706 |
| Average price | $5.1887 |
| Largest weekly change | -11.0% (Jul 17, 2024) |
| Weeks tracked | 185 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Butalbital, Acetaminophen, Caffeine and Codeine Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Barbiturate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP, manufactured by Hikma Pharmaceuticals USA Inc., is $5.2969 per EA (NDC 00054065025), effective Sep 30, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has declined 7.0%. It has been tracked across 185 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
Since Mar 22, 2023, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has ranged from a low of $4.1553 (Feb 19, 2025) to a high of $5.6960 (Apr 10, 2024), with a median of $5.2706 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP (NDC 00054065025) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.